# Anti-inflammatory Effects of GTS-21 After LPS

> **NCT00783068** · NA · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 12 (actual)

## Conditions studied

- Endotoxemia
- Sepsis
- Vagal Activity

## Interventions

- **DRUG:** GTS-21, [3-(2,4-dimethoxybenzylidene)-anabaseine dihydrochloride]
- **DRUG:** Placebo
- **DRUG:** Lipopolysaccharide E. Coli 113:H 10:K negative

## Key facts

- **NCT ID:** NCT00783068
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2009-12
- **Final completion:** 2010-08
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2010-11-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00783068

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00783068, "Anti-inflammatory Effects of GTS-21 After LPS". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00783068. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*